Oncodesign Precision Medicine | Sustainability Performance
This company focuses on precision medicine, particularly in oncology. It engages in the development of targeted therapies and diagnostic tools to support personalized treatment approaches within the healthcare industry.
1995
France
1,001 - 5,000 employees
Biotechnology
$100K - 500K in revenue
Not profitable
Submit or report inaccurate dataDownload Company InsightsⓘBy downloading this report, you'll receive the most insightful and detailed analysis of the company's sustainability performance, compared to its peers. It includes key industry trends, carbon and energy intensity, nature impact, social metrics, and an in-depth look at key risks and controversies.
Sustainability Ranking & Industry Benchmark
#3928
Overallⓘ#259
in Franceⓘ#61
in BiotechnologyⓘSustainability Maturity
ⓘSustainability Intent
ⓘOverview
Environmental
Digital emissions
Controversy level
- Oncodesign's drug discovery services involve animal testing for preclinical studies, raising ethical concerns about the extent of animal use.
Sustainability employees
ⓘWe follow the strictest rules to ensure compliance with all the relevant data protection laws, including GDPR. Click here for our Privacy Policy.Total sustainability employees
7-10
ⓘThis value represents the estimated number of employees in a company with sustainability-related roles or job titles, as determined by Illuminem using publicly available data.